Form 4: HealthEquity Director Robert Selander Reports Stock Transactions
SEC Form 4 Filing
Director Robert Selander reports acquisition of 2,543 common stock shares and holds 47,969 shares, along with stock options.
Summary
- Robert W Selander, a director of HealthEquity, Inc., filed a Form 4 with the SEC.
- The filing reports a transaction date of July 5, 2024.
- Selander acquired 2,543 shares of common stock at $0, bringing his total holdings to 47,969 shares.
- He also holds options to purchase 50,000 shares at $28.68, exercisable from September 29, 2025, and 15,000 shares at $21.27, exercisable from February 1, 2026.
- The restricted stock units vest in full on the earlier of July 5, 2025 or the date of the issuer's next annual stockholder meeting.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard SEC filing reporting insider transactions. The acquisition of shares is mildly positive, but it's not a major event.
Positives
- The director's acquisition of shares could be interpreted as a positive signal about their confidence in the company's future prospects.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting of restricted stock units and exercisability of stock options in the future suggest a continued relationship between the director and the company.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors for signals about management's view of the company's prospects.
Comparison to Industry Standards
- Comparing HealthEquity's insider transactions to those of competitors like HSA Bank or Optum Financial can provide insights into relative management confidence.
- Analyzing the vesting schedules and exercise prices of stock options against industry norms helps assess the attractiveness of HealthEquity's compensation packages.
- Benchmarking HealthEquity's insider ownership levels against similar companies offers a perspective on alignment between management and shareholder interests.
Stakeholder Impact
- Shareholders may view the director's stock acquisition as a positive sign.
- The filing provides transparency to the market regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 06/26/2023 | Date of Power of Attorney filing by Mr. Selander with the SEC. |
| 07/05/2024 | Date of the reported stock transaction. |
| 07/05/2025 | Restricted stock units vest in full on the earlier of this date or the date of the issuer's next annual stockholder meeting. |
| 09/29/2025 | Stock options for 50,000 shares become exercisable. |
| 02/01/2026 | Stock options for 15,000 shares become exercisable. |
| 07/09/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.